NANNI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.362
AS - Asia 2.170
EU - Europa 1.857
AF - Africa 153
SA - Sud America 152
Totale 6.694
Nazione #
US - Stati Uniti d'America 2.337
SG - Singapore 689
CN - Cina 669
VN - Vietnam 379
GB - Regno Unito 359
IT - Italia 348
DE - Germania 324
SE - Svezia 244
HK - Hong Kong 157
IN - India 110
RU - Federazione Russa 106
BR - Brasile 103
FI - Finlandia 100
NL - Olanda 86
FR - Francia 70
KR - Corea 69
IE - Irlanda 63
CI - Costa d'Avorio 43
TG - Togo 42
JO - Giordania 28
SC - Seychelles 28
ZA - Sudafrica 26
UA - Ucraina 25
AR - Argentina 22
EE - Estonia 21
JP - Giappone 21
AT - Austria 18
BG - Bulgaria 18
CH - Svizzera 17
CA - Canada 16
BE - Belgio 15
ES - Italia 14
ID - Indonesia 14
NG - Nigeria 10
PL - Polonia 9
IR - Iran 7
MX - Messico 7
IQ - Iraq 6
PY - Paraguay 6
CL - Cile 5
EC - Ecuador 5
SK - Slovacchia (Repubblica Slovacca) 5
TR - Turchia 4
VE - Venezuela 4
AL - Albania 3
BD - Bangladesh 3
HR - Croazia 3
IL - Israele 3
LT - Lituania 3
BN - Brunei Darussalam 2
CO - Colombia 2
KZ - Kazakistan 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
AO - Angola 1
BO - Bolivia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
LK - Sri Lanka 1
ML - Mali 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 6.694
Città #
Singapore 445
Ashburn 320
Southend 308
Chandler 242
Fairfield 179
Hefei 167
Hong Kong 157
Seattle 114
Munich 106
Santa Clara 104
Woodbridge 96
Beijing 94
Houston 93
Dong Ket 89
Princeton 86
Wilmington 86
Helsinki 80
Cambridge 74
Seoul 69
Hanoi 64
Boardman 63
Dublin 63
Bologna 58
Ho Chi Minh City 57
Dallas 51
Ann Arbor 50
Abidjan 43
Lomé 42
Florence 38
Los Angeles 36
New York 33
Berlin 32
Westminster 32
Nanjing 30
Amman 28
Frankfurt am Main 22
Redondo Beach 21
Buffalo 20
Padova 20
Turin 19
Jinan 18
Tokyo 18
Bengaluru 17
Bremen 17
Guangzhou 17
Saint Petersburg 16
Tianjin 16
Sofia 15
Bern 14
San Diego 14
Shenyang 14
Brussels 13
Hebei 13
Jacksonville 13
Milan 13
London 12
Chicago 11
Nuremberg 11
Redmond 11
São Paulo 11
Changsha 10
Nanchang 10
Rome 10
The Dalles 10
Abeokuta 9
Des Moines 9
Redwood City 9
Brooklyn 8
Falls Church 8
Haiphong 8
Jakarta 8
Jiaxing 8
Medford 8
Orem 8
Tongling 8
Haikou 7
Hangzhou 7
Hyderabad 7
Kuban 7
Mülheim 7
Toronto 7
Turku 7
Vienna 7
Yubileyny 7
Zhengzhou 7
Amsterdam 6
Council Bluffs 6
Dearborn 6
Fuzhou 6
Norwalk 6
San Francisco 6
Shanghai 6
Taizhou 6
Arezzo 5
Boston 5
Cesena 5
Falkenstein 5
Genoa 5
Jyväskylä 5
Lappeenranta 5
Totale 4.299
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 274
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 270
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial 193
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 192
A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role? 188
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 181
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 177
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 174
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 165
Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity 160
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 151
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma 149
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 149
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 148
18F-FACBC PET/CT VS. 11C-CHOLINE FOR THE DETECTION OF PROSTATE CANCER RELAPSE AFTER RADICAL TREATMENT 145
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 144
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL. 144
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 144
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 136
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 135
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 134
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 133
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 132
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA 132
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group 130
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 128
Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report 128
Report of the 6th International Workshop on PET in lymphoma 126
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial 124
Psychometric Properties of the Italian Version of the Short-Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-It): A Multicenter Validation Study 121
The role of 18F-FDG PET/CT in soft tissue sarcoma 119
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. 116
Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view. 114
Therapy assessment in multiple myeloma with PET 114
Yttrium 90 Intra Arterial Radioembolization Therapy of Unresectable Intrahepatic Cholangiocarcinoma: 5 Year Experience at a Single Center 110
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial 110
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET 109
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 102
USEFULNESS OF 11C-CHOLINE PET/CT IMAGING FOR DETECTION OF LYNPHONODE INVOLVENT IN NEWLY DIAGNOSED PROSTATE CANCER 99
Glucose metabolism quantified by suvmax on baseline fdg-pet/ct predicts survival in newly diagnosed multiple myeloma patients: Combined harmonized analysis of two prospective phase iii trials 99
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma 98
The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option? 94
Functional imaging for therapeutic assessment and minimal residual disease detection in multiple myeloma 89
Methodological framework for radiomics applications in Hodgkin’s lymphoma 88
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? 88
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials 86
Interest of pet imaging in multiple myeloma 85
Spine Infections: The Role of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in the Context of the Actual Diagnosis Guideline 71
Skeletal survey in multiple myeloma: Role of imaging 71
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma 69
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 64
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [68Ga]Ga-FAPI PET/CT 63
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma 47
Learned Deep Radiomics for Survival Analysis with Attention 40
Therapeutic potential of lorlatinib in ALK-mutated metastatic paraganglioma: Insights from clinical case report and literature review 15
Totale 6.867
Categoria #
all - tutte 20.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 32 17 47 65 24 24 153
2021/2022871 110 32 43 60 80 27 18 56 26 55 231 133
2022/2023994 96 160 64 128 62 74 29 61 151 33 98 38
2023/2024305 41 38 17 22 31 55 19 21 7 18 27 9
2024/20251.444 51 128 123 113 150 86 166 76 55 126 92 278
2025/20261.708 379 292 300 244 348 145 0 0 0 0 0 0
Totale 6.867